Amarnath Securities Limited
Amarnath Securities Limited (AMARSEC.BO) Stock Competitors & Peer Comparison
See (AMARSEC.BO) competitors and their performances in Stock Market.
Peer Comparison Table: Investment - Banking & Investment Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AMARSEC.BO | ₹12.04 | -10.81% | 40.3M | 23.58 | ₹0.57 | N/A |
| MEDIASSIST.NS | ₹388.50 | +0.96% | 27.7B | 47.20 | ₹7.85 | N/A |
| AQFINTECH.BO | ₹1,226.85 | -0.16% | 19.2B | 1095.40 | ₹1.12 | N/A |
| LKPFIN.BO | ₹181.30 | -3.82% | 11.4B | -558.28 | -₹0.32 | N/A |
| INDPRUD.BO | ₹6,748.95 | +3.83% | 11.3B | 18.08 | ₹373.22 | +1.63% |
| MASTERTR.BO | ₹91.56 | -0.48% | 11.2B | 9.35 | ₹9.71 | N/A |
| AKCAPIT.BO | ₹1,590.00 | +3.09% | 10.5B | 10.10 | ₹157.47 | +3.27% |
| SYSTMTXC.BO | ₹67.66 | +2.90% | 9B | 31.56 | ₹2.10 | +0.15% |
| GCSL.BO | ₹378.80 | -3.53% | 8.6B | -63.53 | -₹5.95 | +0.12% |
| ARYAMAN.BO | ₹600.15 | -1.78% | 7.4B | 25.42 | ₹23.76 | N/A |
Stock Comparison
AMARSEC.BO vs MEDIASSIST.NS Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, MEDIASSIST.NS has a market cap of 27.7B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while MEDIASSIST.NS trades at ₹388.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas MEDIASSIST.NS's P/E ratio is 47.20. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to MEDIASSIST.NS's ROE of +0.14%. Regarding short-term risk, AMARSEC.BO is less volatile compared to MEDIASSIST.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check MEDIASSIST.NS's competition here
AMARSEC.BO vs AQFINTECH.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, AQFINTECH.BO has a market cap of 19.2B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while AQFINTECH.BO trades at ₹1,226.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas AQFINTECH.BO's P/E ratio is 1095.40. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to AQFINTECH.BO's ROE of +0.12%. Regarding short-term risk, AMARSEC.BO is more volatile compared to AQFINTECH.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check AQFINTECH.BO's competition here
AMARSEC.BO vs LKPFIN.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, LKPFIN.BO has a market cap of 11.4B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while LKPFIN.BO trades at ₹181.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas LKPFIN.BO's P/E ratio is -558.28. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to LKPFIN.BO's ROE of -0.01%. Regarding short-term risk, AMARSEC.BO is more volatile compared to LKPFIN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check LKPFIN.BO's competition here
AMARSEC.BO vs INDPRUD.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, INDPRUD.BO has a market cap of 11.3B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while INDPRUD.BO trades at ₹6,748.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas INDPRUD.BO's P/E ratio is 18.08. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to INDPRUD.BO's ROE of +0.08%. Regarding short-term risk, AMARSEC.BO is more volatile compared to INDPRUD.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check INDPRUD.BO's competition here
AMARSEC.BO vs MASTERTR.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, MASTERTR.BO has a market cap of 11.2B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while MASTERTR.BO trades at ₹91.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas MASTERTR.BO's P/E ratio is 9.35. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to MASTERTR.BO's ROE of +0.18%. Regarding short-term risk, AMARSEC.BO is more volatile compared to MASTERTR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check MASTERTR.BO's competition here
AMARSEC.BO vs AKCAPIT.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, AKCAPIT.BO has a market cap of 10.5B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while AKCAPIT.BO trades at ₹1,590.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas AKCAPIT.BO's P/E ratio is 10.10. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to AKCAPIT.BO's ROE of +0.10%. Regarding short-term risk, AMARSEC.BO is more volatile compared to AKCAPIT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check AKCAPIT.BO's competition here
AMARSEC.BO vs SYSTMTXC.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, SYSTMTXC.BO has a market cap of 9B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while SYSTMTXC.BO trades at ₹67.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas SYSTMTXC.BO's P/E ratio is 31.56. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to SYSTMTXC.BO's ROE of +0.09%. Regarding short-term risk, AMARSEC.BO is less volatile compared to SYSTMTXC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check SYSTMTXC.BO's competition here
AMARSEC.BO vs GCSL.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, GCSL.BO has a market cap of 8.6B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while GCSL.BO trades at ₹378.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas GCSL.BO's P/E ratio is -63.53. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to GCSL.BO's ROE of +0.09%. Regarding short-term risk, AMARSEC.BO is less volatile compared to GCSL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check GCSL.BO's competition here
AMARSEC.BO vs ARYAMAN.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, ARYAMAN.BO has a market cap of 7.4B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while ARYAMAN.BO trades at ₹600.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas ARYAMAN.BO's P/E ratio is 25.42. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to ARYAMAN.BO's ROE of +0.23%. Regarding short-term risk, AMARSEC.BO is more volatile compared to ARYAMAN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check ARYAMAN.BO's competition here
AMARSEC.BO vs ARYACAPM.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, ARYACAPM.BO has a market cap of 5.1B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while ARYACAPM.BO trades at ₹412.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas ARYACAPM.BO's P/E ratio is 17.70. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to ARYACAPM.BO's ROE of +0.14%. Regarding short-term risk, AMARSEC.BO is less volatile compared to ARYACAPM.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check ARYACAPM.BO's competition here
AMARSEC.BO vs SRAMSET.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, SRAMSET.BO has a market cap of 5.1B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while SRAMSET.BO trades at ₹298.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas SRAMSET.BO's P/E ratio is -26.34. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to SRAMSET.BO's ROE of -0.18%. Regarding short-term risk, AMARSEC.BO is less volatile compared to SRAMSET.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check SRAMSET.BO's competition here
AMARSEC.BO vs KIRANVYPAR.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, KIRANVYPAR.BO has a market cap of 5B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while KIRANVYPAR.BO trades at ₹177.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas KIRANVYPAR.BO's P/E ratio is 287.97. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to KIRANVYPAR.BO's ROE of +0.00%. Regarding short-term risk, AMARSEC.BO is less volatile compared to KIRANVYPAR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check KIRANVYPAR.BO's competition here
AMARSEC.BO vs UCIL.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, UCIL.BO has a market cap of 4.4B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while UCIL.BO trades at ₹98.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas UCIL.BO's P/E ratio is 4.52. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to UCIL.BO's ROE of +0.77%. Regarding short-term risk, AMARSEC.BO is less volatile compared to UCIL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check UCIL.BO's competition here
AMARSEC.BO vs OIVL.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, OIVL.BO has a market cap of 3.3B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while OIVL.BO trades at ₹6.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas OIVL.BO's P/E ratio is -1.00. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to OIVL.BO's ROE of +0.88%. Regarding short-term risk, AMARSEC.BO is less volatile compared to OIVL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check OIVL.BO's competition here
AMARSEC.BO vs ALSL.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, ALSL.BO has a market cap of 3.2B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while ALSL.BO trades at ₹69.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas ALSL.BO's P/E ratio is 48.56. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to ALSL.BO's ROE of +0.08%. Regarding short-term risk, AMARSEC.BO is less volatile compared to ALSL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check ALSL.BO's competition here
AMARSEC.BO vs IMCAP.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, IMCAP.BO has a market cap of 3.2B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while IMCAP.BO trades at ₹914.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas IMCAP.BO's P/E ratio is 229.89. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to IMCAP.BO's ROE of +0.29%. Regarding short-term risk, AMARSEC.BO is more volatile compared to IMCAP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check IMCAP.BO's competition here
AMARSEC.BO vs HAMPTON.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, HAMPTON.BO has a market cap of 2.8B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while HAMPTON.BO trades at ₹10.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas HAMPTON.BO's P/E ratio is -16.03. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to HAMPTON.BO's ROE of -0.09%. Regarding short-term risk, AMARSEC.BO is less volatile compared to HAMPTON.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check HAMPTON.BO's competition here
AMARSEC.BO vs QUESTCAP.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, QUESTCAP.BO has a market cap of 2.6B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while QUESTCAP.BO trades at ₹261.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas QUESTCAP.BO's P/E ratio is 6.57. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to QUESTCAP.BO's ROE of +0.03%. Regarding short-term risk, AMARSEC.BO is less volatile compared to QUESTCAP.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check QUESTCAP.BO's competition here
AMARSEC.BO vs NIDHGRN.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, NIDHGRN.BO has a market cap of 2.6B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while NIDHGRN.BO trades at ₹335.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas NIDHGRN.BO's P/E ratio is 53.59. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to NIDHGRN.BO's ROE of +0.31%. Regarding short-term risk, AMARSEC.BO is more volatile compared to NIDHGRN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check NIDHGRN.BO's competition here
AMARSEC.BO vs SHARDUL.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, SHARDUL.BO has a market cap of 2.5B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while SHARDUL.BO trades at ₹28.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas SHARDUL.BO's P/E ratio is -4.60. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to SHARDUL.BO's ROE of -0.07%. Regarding short-term risk, AMARSEC.BO is less volatile compared to SHARDUL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check SHARDUL.BO's competition here
AMARSEC.BO vs REGENCY.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, REGENCY.BO has a market cap of 2.4B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while REGENCY.BO trades at ₹33.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas REGENCY.BO's P/E ratio is 25.04. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to REGENCY.BO's ROE of +0.11%. Regarding short-term risk, AMARSEC.BO is less volatile compared to REGENCY.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check REGENCY.BO's competition here
AMARSEC.BO vs PHCAP.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, PHCAP.BO has a market cap of 2.3B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while PHCAP.BO trades at ₹750.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas PHCAP.BO's P/E ratio is 70.70. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to PHCAP.BO's ROE of +0.06%. Regarding short-term risk, AMARSEC.BO is more volatile compared to PHCAP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check PHCAP.BO's competition here
AMARSEC.BO vs VISCO.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, VISCO.BO has a market cap of 2.2B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while VISCO.BO trades at ₹92.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas VISCO.BO's P/E ratio is 7.50. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to VISCO.BO's ROE of -0.08%. Regarding short-term risk, AMARSEC.BO is more volatile compared to VISCO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check VISCO.BO's competition here
AMARSEC.BO vs SODFC.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, SODFC.BO has a market cap of 2.1B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while SODFC.BO trades at ₹124.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas SODFC.BO's P/E ratio is -1782.86. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to SODFC.BO's ROE of +0.01%. Regarding short-term risk, AMARSEC.BO is less volatile compared to SODFC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check SODFC.BO's competition here
AMARSEC.BO vs PROFINC.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, PROFINC.BO has a market cap of 2.1B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while PROFINC.BO trades at ₹3.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas PROFINC.BO's P/E ratio is 14.92. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to PROFINC.BO's ROE of -0.03%. Regarding short-term risk, AMARSEC.BO is more volatile compared to PROFINC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check PROFINC.BO's competition here
AMARSEC.BO vs TAMBOLIIN.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, TAMBOLIIN.BO has a market cap of 1.7B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while TAMBOLIIN.BO trades at ₹166.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas TAMBOLIIN.BO's P/E ratio is 20.53. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to TAMBOLIIN.BO's ROE of +0.08%. Regarding short-term risk, AMARSEC.BO is more volatile compared to TAMBOLIIN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check TAMBOLIIN.BO's competition here
AMARSEC.BO vs JHACC.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, JHACC.BO has a market cap of 1.7B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while JHACC.BO trades at ₹175.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas JHACC.BO's P/E ratio is 131.41. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to JHACC.BO's ROE of +0.01%. Regarding short-term risk, AMARSEC.BO is less volatile compared to JHACC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check JHACC.BO's competition here
AMARSEC.BO vs LKPSEC.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, LKPSEC.BO has a market cap of 1.6B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while LKPSEC.BO trades at ₹19.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas LKPSEC.BO's P/E ratio is 15.21. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to LKPSEC.BO's ROE of +0.11%. Regarding short-term risk, AMARSEC.BO is more volatile compared to LKPSEC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check LKPSEC.BO's competition here
AMARSEC.BO vs PIONRINV.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, PIONRINV.BO has a market cap of 1.5B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while PIONRINV.BO trades at ₹119.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas PIONRINV.BO's P/E ratio is 8.76. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to PIONRINV.BO's ROE of +0.11%. Regarding short-term risk, AMARSEC.BO is less volatile compared to PIONRINV.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check PIONRINV.BO's competition here
AMARSEC.BO vs CGFL.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, CGFL.BO has a market cap of 1.4B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while CGFL.BO trades at ₹27.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas CGFL.BO's P/E ratio is 5.32. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to CGFL.BO's ROE of +0.37%. Regarding short-term risk, AMARSEC.BO is more volatile compared to CGFL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check CGFL.BO's competition here
AMARSEC.BO vs ARIHCAPM.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, ARIHCAPM.BO has a market cap of 1.4B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while ARIHCAPM.BO trades at ₹68.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas ARIHCAPM.BO's P/E ratio is 8.17. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to ARIHCAPM.BO's ROE of +0.09%. Regarding short-term risk, AMARSEC.BO is more volatile compared to ARIHCAPM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check ARIHCAPM.BO's competition here
AMARSEC.BO vs UPSURGE.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, UPSURGE.BO has a market cap of 1.4B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while UPSURGE.BO trades at ₹63.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas UPSURGE.BO's P/E ratio is 15.25. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to UPSURGE.BO's ROE of +0.09%. Regarding short-term risk, AMARSEC.BO is more volatile compared to UPSURGE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check UPSURGE.BO's competition here
AMARSEC.BO vs PMCFIN.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, PMCFIN.BO has a market cap of 1.4B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while PMCFIN.BO trades at ₹1.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas PMCFIN.BO's P/E ratio is 23.75. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to PMCFIN.BO's ROE of +0.05%. Regarding short-term risk, AMARSEC.BO is more volatile compared to PMCFIN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check PMCFIN.BO's competition here
AMARSEC.BO vs DHARNI.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, DHARNI.BO has a market cap of 1.3B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while DHARNI.BO trades at ₹65.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas DHARNI.BO's P/E ratio is 46.43. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to DHARNI.BO's ROE of +0.19%. Regarding short-term risk, AMARSEC.BO is more volatile compared to DHARNI.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check DHARNI.BO's competition here
AMARSEC.BO vs SWASTIKA.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, SWASTIKA.BO has a market cap of 1.3B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while SWASTIKA.BO trades at ₹64.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas SWASTIKA.BO's P/E ratio is 9.69. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to SWASTIKA.BO's ROE of +0.11%. Regarding short-term risk, AMARSEC.BO is more volatile compared to SWASTIKA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check SWASTIKA.BO's competition here
AMARSEC.BO vs VGCL.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, VGCL.BO has a market cap of 1.3B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while VGCL.BO trades at ₹57.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas VGCL.BO's P/E ratio is 60.30. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to VGCL.BO's ROE of +0.01%. Regarding short-term risk, AMARSEC.BO is more volatile compared to VGCL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check VGCL.BO's competition here
AMARSEC.BO vs VISTARAMAR.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, VISTARAMAR.BO has a market cap of 1.2B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while VISTARAMAR.BO trades at ₹212.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas VISTARAMAR.BO's P/E ratio is 23.57. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to VISTARAMAR.BO's ROE of +0.16%. Regarding short-term risk, AMARSEC.BO is less volatile compared to VISTARAMAR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check VISTARAMAR.BO's competition here
AMARSEC.BO vs SCL.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, SCL.BO has a market cap of 1.2B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while SCL.BO trades at ₹0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas SCL.BO's P/E ratio is 4.60. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to SCL.BO's ROE of +0.03%. Regarding short-term risk, AMARSEC.BO is less volatile compared to SCL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check SCL.BO's competition here
AMARSEC.BO vs ESCORP.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, ESCORP.BO has a market cap of 1.2B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while ESCORP.BO trades at ₹108.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas ESCORP.BO's P/E ratio is 25.44. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to ESCORP.BO's ROE of +0.03%. Regarding short-term risk, AMARSEC.BO is less volatile compared to ESCORP.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check ESCORP.BO's competition here
AMARSEC.BO vs ASSAMENT.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, ASSAMENT.BO has a market cap of 1.2B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while ASSAMENT.BO trades at ₹800.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas ASSAMENT.BO's P/E ratio is 24.76. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to ASSAMENT.BO's ROE of +0.07%. Regarding short-term risk, AMARSEC.BO is more volatile compared to ASSAMENT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check ASSAMENT.BO's competition here
AMARSEC.BO vs TITANSEC.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, TITANSEC.BO has a market cap of 1.1B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while TITANSEC.BO trades at ₹44.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas TITANSEC.BO's P/E ratio is 9.70. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to TITANSEC.BO's ROE of +0.11%. Regarding short-term risk, AMARSEC.BO is more volatile compared to TITANSEC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check TITANSEC.BO's competition here
AMARSEC.BO vs NAYSAA.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, NAYSAA.BO has a market cap of 1.1B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while NAYSAA.BO trades at ₹307.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas NAYSAA.BO's P/E ratio is 379.26. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to NAYSAA.BO's ROE of +0.57%. Regarding short-term risk, AMARSEC.BO is less volatile compared to NAYSAA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check NAYSAA.BO's competition here
AMARSEC.BO vs MUNCAPM.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, MUNCAPM.BO has a market cap of 1B. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while MUNCAPM.BO trades at ₹111.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas MUNCAPM.BO's P/E ratio is 506.82. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to MUNCAPM.BO's ROE of +0.03%. Regarding short-term risk, AMARSEC.BO is more volatile compared to MUNCAPM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check MUNCAPM.BO's competition here
AMARSEC.BO vs ASITCFIN.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, ASITCFIN.BO has a market cap of 987M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while ASITCFIN.BO trades at ₹119.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas ASITCFIN.BO's P/E ratio is -133.00. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to ASITCFIN.BO's ROE of -0.03%. Regarding short-term risk, AMARSEC.BO is more volatile compared to ASITCFIN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check ASITCFIN.BO's competition here
AMARSEC.BO vs AARNAV.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, AARNAV.BO has a market cap of 943.6M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while AARNAV.BO trades at ₹22.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas AARNAV.BO's P/E ratio is 13.22. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to AARNAV.BO's ROE of +0.04%. Regarding short-term risk, AMARSEC.BO is more volatile compared to AARNAV.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check AARNAV.BO's competition here
AMARSEC.BO vs INDUSFINL.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, INDUSFINL.BO has a market cap of 934.3M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while INDUSFINL.BO trades at ₹103.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas INDUSFINL.BO's P/E ratio is 148.40. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to INDUSFINL.BO's ROE of +0.09%. Regarding short-term risk, AMARSEC.BO is less volatile compared to INDUSFINL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check INDUSFINL.BO's competition here
AMARSEC.BO vs ADVIKCA.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, ADVIKCA.BO has a market cap of 882.4M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while ADVIKCA.BO trades at ₹1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas ADVIKCA.BO's P/E ratio is -3.92. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to ADVIKCA.BO's ROE of -0.10%. Regarding short-term risk, AMARSEC.BO is more volatile compared to ADVIKCA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check ADVIKCA.BO's competition here
AMARSEC.BO vs MUKESHB.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, MUKESHB.BO has a market cap of 873.5M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while MUKESHB.BO trades at ₹113.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas MUKESHB.BO's P/E ratio is 14.60. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to MUKESHB.BO's ROE of +0.02%. Regarding short-term risk, AMARSEC.BO is less volatile compared to MUKESHB.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check MUKESHB.BO's competition here
AMARSEC.BO vs CHRTEDCA.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, CHRTEDCA.BO has a market cap of 807.1M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while CHRTEDCA.BO trades at ₹268.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas CHRTEDCA.BO's P/E ratio is 10.78. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to CHRTEDCA.BO's ROE of +0.04%. Regarding short-term risk, AMARSEC.BO is more volatile compared to CHRTEDCA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check CHRTEDCA.BO's competition here
AMARSEC.BO vs SAUMYA.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, SAUMYA.BO has a market cap of 793.3M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while SAUMYA.BO trades at ₹114.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas SAUMYA.BO's P/E ratio is -23.16. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to SAUMYA.BO's ROE of -0.03%. Regarding short-term risk, AMARSEC.BO is less volatile compared to SAUMYA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check SAUMYA.BO's competition here
AMARSEC.BO vs MYMONEY.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, MYMONEY.BO has a market cap of 734.2M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while MYMONEY.BO trades at ₹42.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas MYMONEY.BO's P/E ratio is -80.93. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to MYMONEY.BO's ROE of -0.03%. Regarding short-term risk, AMARSEC.BO is less volatile compared to MYMONEY.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check MYMONEY.BO's competition here
AMARSEC.BO vs GOGIACAP.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, GOGIACAP.BO has a market cap of 719M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while GOGIACAP.BO trades at ₹113.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas GOGIACAP.BO's P/E ratio is -2.98. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to GOGIACAP.BO's ROE of -0.01%. Regarding short-term risk, AMARSEC.BO is more volatile compared to GOGIACAP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check GOGIACAP.BO's competition here
AMARSEC.BO vs WALLFORT.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, WALLFORT.BO has a market cap of 699M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while WALLFORT.BO trades at ₹73.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas WALLFORT.BO's P/E ratio is -10.05. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to WALLFORT.BO's ROE of -0.04%. Regarding short-term risk, AMARSEC.BO is more volatile compared to WALLFORT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check WALLFORT.BO's competition here
AMARSEC.BO vs ROYALIND.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, ROYALIND.BO has a market cap of 697.2M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while ROYALIND.BO trades at ₹6.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas ROYALIND.BO's P/E ratio is 13.13. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to ROYALIND.BO's ROE of +0.20%. Regarding short-term risk, AMARSEC.BO is less volatile compared to ROYALIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check ROYALIND.BO's competition here
AMARSEC.BO vs ELIXIR.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, ELIXIR.BO has a market cap of 676.7M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while ELIXIR.BO trades at ₹114.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas ELIXIR.BO's P/E ratio is 30.85. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to ELIXIR.BO's ROE of +0.03%. Regarding short-term risk, AMARSEC.BO is less volatile compared to ELIXIR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check ELIXIR.BO's competition here
AMARSEC.BO vs BNRSEC.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, BNRSEC.BO has a market cap of 675.9M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while BNRSEC.BO trades at ₹17.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas BNRSEC.BO's P/E ratio is -3.30. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to BNRSEC.BO's ROE of +0.10%. Regarding short-term risk, AMARSEC.BO is less volatile compared to BNRSEC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check BNRSEC.BO's competition here
AMARSEC.BO vs SKPSEC.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, SKPSEC.BO has a market cap of 672M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while SKPSEC.BO trades at ₹101.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas SKPSEC.BO's P/E ratio is 7.00. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to SKPSEC.BO's ROE of +0.19%. Regarding short-term risk, AMARSEC.BO is more volatile compared to SKPSEC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check SKPSEC.BO's competition here
AMARSEC.BO vs BAMPSL.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, BAMPSL.BO has a market cap of 651.1M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while BAMPSL.BO trades at ₹19.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas BAMPSL.BO's P/E ratio is 32.98. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to BAMPSL.BO's ROE of +0.06%. Regarding short-term risk, AMARSEC.BO is less volatile compared to BAMPSL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check BAMPSL.BO's competition here
AMARSEC.BO vs JOINDRE.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, JOINDRE.BO has a market cap of 650.3M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while JOINDRE.BO trades at ₹47.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas JOINDRE.BO's P/E ratio is 8.33. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to JOINDRE.BO's ROE of +0.10%. Regarding short-term risk, AMARSEC.BO is less volatile compared to JOINDRE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check JOINDRE.BO's competition here
AMARSEC.BO vs HBPOR.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, HBPOR.BO has a market cap of 645.9M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while HBPOR.BO trades at ₹59.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas HBPOR.BO's P/E ratio is 39.22. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to HBPOR.BO's ROE of +0.00%. Regarding short-term risk, AMARSEC.BO is less volatile compared to HBPOR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check HBPOR.BO's competition here
AMARSEC.BO vs GOWRALE.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, GOWRALE.BO has a market cap of 635.3M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while GOWRALE.BO trades at ₹81.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas GOWRALE.BO's P/E ratio is 8.60. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to GOWRALE.BO's ROE of +0.21%. Regarding short-term risk, AMARSEC.BO is more volatile compared to GOWRALE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check GOWRALE.BO's competition here
AMARSEC.BO vs DHANCOT.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, DHANCOT.BO has a market cap of 590.4M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while DHANCOT.BO trades at ₹121.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas DHANCOT.BO's P/E ratio is -42.23. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to DHANCOT.BO's ROE of -0.02%. Regarding short-term risk, AMARSEC.BO is less volatile compared to DHANCOT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check DHANCOT.BO's competition here
AMARSEC.BO vs MEAPL.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, MEAPL.BO has a market cap of 568.1M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while MEAPL.BO trades at ₹38.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas MEAPL.BO's P/E ratio is 3.33. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to MEAPL.BO's ROE of +0.31%. Regarding short-term risk, AMARSEC.BO is less volatile compared to MEAPL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check MEAPL.BO's competition here
AMARSEC.BO vs LADDERUP.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, LADDERUP.BO has a market cap of 564.2M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while LADDERUP.BO trades at ₹58.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas LADDERUP.BO's P/E ratio is 35.01. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to LADDERUP.BO's ROE of +0.02%. Regarding short-term risk, AMARSEC.BO is less volatile compared to LADDERUP.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check LADDERUP.BO's competition here
AMARSEC.BO vs MEFCOMCAP.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, MEFCOMCAP.BO has a market cap of 548.4M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while MEFCOMCAP.BO trades at ₹11.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas MEFCOMCAP.BO's P/E ratio is -42.86. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to MEFCOMCAP.BO's ROE of -0.05%. Regarding short-term risk, AMARSEC.BO is less volatile compared to MEFCOMCAP.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check MEFCOMCAP.BO's competition here
AMARSEC.BO vs ISLCONSUL.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, ISLCONSUL.BO has a market cap of 512.9M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while ISLCONSUL.BO trades at ₹21.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas ISLCONSUL.BO's P/E ratio is -61.06. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to ISLCONSUL.BO's ROE of -0.06%. Regarding short-term risk, AMARSEC.BO is more volatile compared to ISLCONSUL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check ISLCONSUL.BO's competition here
AMARSEC.BO vs BRIDGESE.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, BRIDGESE.BO has a market cap of 502.5M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while BRIDGESE.BO trades at ₹15.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas BRIDGESE.BO's P/E ratio is 38.88. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to BRIDGESE.BO's ROE of +0.37%. Regarding short-term risk, AMARSEC.BO is more volatile compared to BRIDGESE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check BRIDGESE.BO's competition here
AMARSEC.BO vs SMIFS.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, SMIFS.BO has a market cap of 479.7M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while SMIFS.BO trades at ₹81.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas SMIFS.BO's P/E ratio is 41.44. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to SMIFS.BO's ROE of +0.01%. Regarding short-term risk, AMARSEC.BO is less volatile compared to SMIFS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check SMIFS.BO's competition here
AMARSEC.BO vs KIDUJA.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, KIDUJA.BO has a market cap of 478.8M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while KIDUJA.BO trades at ₹19.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas KIDUJA.BO's P/E ratio is -21.22. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to KIDUJA.BO's ROE of +0.11%. Regarding short-term risk, AMARSEC.BO is less volatile compared to KIDUJA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check KIDUJA.BO's competition here
AMARSEC.BO vs SRESTHA.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, SRESTHA.BO has a market cap of 457M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while SRESTHA.BO trades at ₹0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas SRESTHA.BO's P/E ratio is -1.13. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to SRESTHA.BO's ROE of -0.28%. Regarding short-term risk, AMARSEC.BO is more volatile compared to SRESTHA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check SRESTHA.BO's competition here
AMARSEC.BO vs NAM.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, NAM.BO has a market cap of 446.1M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while NAM.BO trades at ₹84.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas NAM.BO's P/E ratio is 217.74. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to NAM.BO's ROE of +0.02%. Regarding short-term risk, AMARSEC.BO is more volatile compared to NAM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check NAM.BO's competition here
AMARSEC.BO vs SITAENT.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, SITAENT.BO has a market cap of 440.3M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while SITAENT.BO trades at ₹146.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas SITAENT.BO's P/E ratio is 8.39. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to SITAENT.BO's ROE of +0.32%. Regarding short-term risk, AMARSEC.BO is less volatile compared to SITAENT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check SITAENT.BO's competition here
AMARSEC.BO vs SAICAPI.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, SAICAPI.BO has a market cap of 433.9M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while SAICAPI.BO trades at ₹149.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas SAICAPI.BO's P/E ratio is 2.88. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to SAICAPI.BO's ROE of +0.04%. Regarding short-term risk, AMARSEC.BO is less volatile compared to SAICAPI.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check SAICAPI.BO's competition here
AMARSEC.BO vs BERVINL.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, BERVINL.BO has a market cap of 421.7M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while BERVINL.BO trades at ₹71.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas BERVINL.BO's P/E ratio is -2.56. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to BERVINL.BO's ROE of -0.69%. Regarding short-term risk, AMARSEC.BO is more volatile compared to BERVINL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check BERVINL.BO's competition here
AMARSEC.BO vs PANINDIAC.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, PANINDIAC.BO has a market cap of 400.7M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while PANINDIAC.BO trades at ₹1.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas PANINDIAC.BO's P/E ratio is -187.00. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to PANINDIAC.BO's ROE of -0.42%. Regarding short-term risk, AMARSEC.BO is more volatile compared to PANINDIAC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check PANINDIAC.BO's competition here
AMARSEC.BO vs AJCON.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, AJCON.BO has a market cap of 397.6M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while AJCON.BO trades at ₹6.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas AJCON.BO's P/E ratio is -650.00. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to AJCON.BO's ROE of -0.00%. Regarding short-term risk, AMARSEC.BO is less volatile compared to AJCON.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check AJCON.BO's competition here
AMARSEC.BO vs ANUPAM.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, ANUPAM.BO has a market cap of 383.3M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while ANUPAM.BO trades at ₹2.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas ANUPAM.BO's P/E ratio is 22.44. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to ANUPAM.BO's ROE of +0.06%. Regarding short-term risk, AMARSEC.BO is more volatile compared to ANUPAM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check ANUPAM.BO's competition here
AMARSEC.BO vs BIOGEN.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, BIOGEN.BO has a market cap of 352M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while BIOGEN.BO trades at ₹0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas BIOGEN.BO's P/E ratio is 13.00. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to BIOGEN.BO's ROE of +0.01%. Regarding short-term risk, AMARSEC.BO is more volatile compared to BIOGEN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check BIOGEN.BO's competition here
AMARSEC.BO vs SUMEDHA.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, SUMEDHA.BO has a market cap of 342.8M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while SUMEDHA.BO trades at ₹42.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas SUMEDHA.BO's P/E ratio is 6.86. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to SUMEDHA.BO's ROE of +0.08%. Regarding short-term risk, AMARSEC.BO is more volatile compared to SUMEDHA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check SUMEDHA.BO's competition here
AMARSEC.BO vs SHRINIWAS.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, SHRINIWAS.BO has a market cap of 337.2M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while SHRINIWAS.BO trades at ₹10.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas SHRINIWAS.BO's P/E ratio is N/A. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to SHRINIWAS.BO's ROE of +0.19%. Regarding short-term risk, AMARSEC.BO is less volatile compared to SHRINIWAS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check SHRINIWAS.BO's competition here
AMARSEC.BO vs GOLDLINE.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, GOLDLINE.BO has a market cap of 317.8M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while GOLDLINE.BO trades at ₹0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas GOLDLINE.BO's P/E ratio is 610.00. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to GOLDLINE.BO's ROE of +0.00%. Regarding short-term risk, AMARSEC.BO is less volatile compared to GOLDLINE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check GOLDLINE.BO's competition here
AMARSEC.BO vs SPCAPIT.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, SPCAPIT.BO has a market cap of 316.7M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while SPCAPIT.BO trades at ₹53.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas SPCAPIT.BO's P/E ratio is 5.01. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to SPCAPIT.BO's ROE of +0.12%. Regarding short-term risk, AMARSEC.BO is more volatile compared to SPCAPIT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check SPCAPIT.BO's competition here
AMARSEC.BO vs ARNOLD.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, ARNOLD.BO has a market cap of 315.3M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while ARNOLD.BO trades at ₹13.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas ARNOLD.BO's P/E ratio is 28.83. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to ARNOLD.BO's ROE of +0.02%. Regarding short-term risk, AMARSEC.BO is less volatile compared to ARNOLD.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check ARNOLD.BO's competition here
AMARSEC.BO vs SULABEN.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, SULABEN.BO has a market cap of 311.5M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while SULABEN.BO trades at ₹3.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas SULABEN.BO's P/E ratio is 14.09. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to SULABEN.BO's ROE of +0.07%. Regarding short-term risk, AMARSEC.BO is more volatile compared to SULABEN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check SULABEN.BO's competition here
AMARSEC.BO vs ABHIFIN.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, ABHIFIN.BO has a market cap of 309.1M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while ABHIFIN.BO trades at ₹66.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas ABHIFIN.BO's P/E ratio is 1116.67. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to ABHIFIN.BO's ROE of +0.00%. Regarding short-term risk, AMARSEC.BO is more volatile compared to ABHIFIN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check ABHIFIN.BO's competition here
AMARSEC.BO vs GALACTICO.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, GALACTICO.BO has a market cap of 298.5M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while GALACTICO.BO trades at ₹2.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas GALACTICO.BO's P/E ratio is 28.00. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to GALACTICO.BO's ROE of +0.04%. Regarding short-term risk, AMARSEC.BO is less volatile compared to GALACTICO.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check GALACTICO.BO's competition here
AMARSEC.BO vs INDIANVSH.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, INDIANVSH.BO has a market cap of 285.8M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while INDIANVSH.BO trades at ₹7.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas INDIANVSH.BO's P/E ratio is -3.25. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to INDIANVSH.BO's ROE of +0.24%. Regarding short-term risk, AMARSEC.BO is less volatile compared to INDIANVSH.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check INDIANVSH.BO's competition here
AMARSEC.BO vs STANROS.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, STANROS.BO has a market cap of 277M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while STANROS.BO trades at ₹70.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas STANROS.BO's P/E ratio is -9.18. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to STANROS.BO's ROE of -0.07%. Regarding short-term risk, AMARSEC.BO is more volatile compared to STANROS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check STANROS.BO's competition here
AMARSEC.BO vs RAMSONS.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, RAMSONS.BO has a market cap of 266.2M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while RAMSONS.BO trades at ₹88.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas RAMSONS.BO's P/E ratio is 3.46. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to RAMSONS.BO's ROE of +0.46%. Regarding short-term risk, AMARSEC.BO is more volatile compared to RAMSONS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check RAMSONS.BO's competition here
AMARSEC.BO vs PURSHOTTAM.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, PURSHOTTAM.BO has a market cap of 260.9M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while PURSHOTTAM.BO trades at ₹35.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas PURSHOTTAM.BO's P/E ratio is 33.16. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to PURSHOTTAM.BO's ROE of +0.01%. Regarding short-term risk, AMARSEC.BO is more volatile compared to PURSHOTTAM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check PURSHOTTAM.BO's competition here
AMARSEC.BO vs STEP2COR.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, STEP2COR.BO has a market cap of 254.7M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while STEP2COR.BO trades at ₹34.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas STEP2COR.BO's P/E ratio is 7.97. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to STEP2COR.BO's ROE of +0.25%. Regarding short-term risk, AMARSEC.BO is less volatile compared to STEP2COR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check STEP2COR.BO's competition here
AMARSEC.BO vs KJMCFIN.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, KJMCFIN.BO has a market cap of 254.4M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while KJMCFIN.BO trades at ₹53.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas KJMCFIN.BO's P/E ratio is 16.93. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to KJMCFIN.BO's ROE of +0.01%. Regarding short-term risk, AMARSEC.BO is more volatile compared to KJMCFIN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check KJMCFIN.BO's competition here
AMARSEC.BO vs ARUNIS.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, ARUNIS.BO has a market cap of 249M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while ARUNIS.BO trades at ₹88.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas ARUNIS.BO's P/E ratio is 48.54. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to ARUNIS.BO's ROE of +0.37%. Regarding short-term risk, AMARSEC.BO is less volatile compared to ARUNIS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check ARUNIS.BO's competition here
AMARSEC.BO vs HELPAGE.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, HELPAGE.BO has a market cap of 222.3M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while HELPAGE.BO trades at ₹22.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas HELPAGE.BO's P/E ratio is 6.86. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to HELPAGE.BO's ROE of +0.19%. Regarding short-term risk, AMARSEC.BO is more volatile compared to HELPAGE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check HELPAGE.BO's competition here
AMARSEC.BO vs GSBFIN.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, GSBFIN.BO has a market cap of 207.2M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while GSBFIN.BO trades at ₹34.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas GSBFIN.BO's P/E ratio is -191.83. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to GSBFIN.BO's ROE of -0.01%. Regarding short-term risk, AMARSEC.BO is less volatile compared to GSBFIN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check GSBFIN.BO's competition here
AMARSEC.BO vs KJMCCORP.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, KJMCCORP.BO has a market cap of 206.3M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while KJMCCORP.BO trades at ₹54.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas KJMCCORP.BO's P/E ratio is 0.10. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to KJMCCORP.BO's ROE of +0.03%. Regarding short-term risk, AMARSEC.BO is more volatile compared to KJMCCORP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check KJMCCORP.BO's competition here
AMARSEC.BO vs VERTEX.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, VERTEX.BO has a market cap of 203.8M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while VERTEX.BO trades at ₹2.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas VERTEX.BO's P/E ratio is -17.87. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to VERTEX.BO's ROE of -0.25%. Regarding short-term risk, AMARSEC.BO is more volatile compared to VERTEX.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check VERTEX.BO's competition here
AMARSEC.BO vs PHOTON.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, PHOTON.BO has a market cap of 201.1M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while PHOTON.BO trades at ₹132.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas PHOTON.BO's P/E ratio is 457.24. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to PHOTON.BO's ROE of -0.07%. Regarding short-term risk, AMARSEC.BO is more volatile compared to PHOTON.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMARSEC.BO.Check PHOTON.BO's competition here
AMARSEC.BO vs GAJANANSEC.BO Comparison May 2026
AMARSEC.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMARSEC.BO stands at 40.3M. In comparison, GAJANANSEC.BO has a market cap of 195.7M. Regarding current trading prices, AMARSEC.BO is priced at ₹12.04, while GAJANANSEC.BO trades at ₹60.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMARSEC.BO currently has a P/E ratio of 23.58, whereas GAJANANSEC.BO's P/E ratio is 26.28. In terms of profitability, AMARSEC.BO's ROE is +0.04%, compared to GAJANANSEC.BO's ROE of +0.01%. Regarding short-term risk, AMARSEC.BO is less volatile compared to GAJANANSEC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMARSEC.BO.Check GAJANANSEC.BO's competition here